Evonext Holdings Sa · SIX:EVE
Evonext Holdings Sa — Evolva Holding — Merger or Acquisition (May 2025)
12 slides from Evonext Holdings Sa's merger presentation, May 27, 2025
Slide 1: Offer for GZO AG
Offer for GZO AG Transforming Evolva Holding SA into a Scalable Healthcare Platform May 27, 2025
Slide 2: Disclaimer
Disclaimer THIS DOCUMENT AND THE INFORMATION CONTAINED HEREIN MUST NOT BE PUBLISHED, DISTRIBUTED OR TRANSMITTED, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEO PLE’S REPUBLIC OF CHINA, JAPAN OR ANY OTHER JURISDICTION
Slide 3: Executive Summary
Executive Summary Evolva Holding SA (“Evolva”) has submitted a fully-funded binding offer to acquire 100% of the equity of GZO AG, owner of the GZO Spital Wetzikon (collectively ”GZO”). GZO is currently facing potential liquidation due to its excessive debt burden. If accepted, Evolva will propose a
Slide 4: Transaction Highlights
Transaction Highlights Step 1 Step 2 Offer to Municipal Shareholders Restructuring Proposal to Creditors Evolva has submitted a fully-funded binding offer to acquire Upon acceptance of the binding offer by GZO 100% of GZO’s equity for CHF 5 million in cash shareholders, Evolva will propose a debt re
Slide 5: Offer Guarantees Continued Operations of GZO Spital Wetzikon
Offer Guarantees Continued Operations of GZO Spital Wetzikon Situation Overview • GZO AG entered insolvency proceedings in April 2024 after failing to refinance a CHF 170 million bond • Construction of the new hospital building was halted following a breakdown with the general contractor • The Zuric
Slide 6: Why the Offer Makes Sense for Creditors and Communities
Why the Offer Makes Sense for Creditors and Communities Offer improves outcomes for all stakeholders Shareholder communities receive cash Shareholders of GZO Capital Requirement Payout under Evolva Old Plan Evolva Proposal % Total Equity AG under Current Plan Plan Based on market Wetzikon 25.5% -12,
Slide 7: Creating Regional Healthcare Platform
Creating Regional Healthcare Platform Capital Access Platform Approach Public listing on SIX will provide the GZO’s strong capitalization will provide enlarged group funding opportunities the foundation for the creation of a and access to capital that GZO would regional healthcare platform. not othe
Slide 8: From Insolvency to Stability: Balance Sheet (post-restructuring)
From Insolvency to Stability Evolva’s restructuring proposal will eliminate GZO’s over-indebtedness entirely and provide it with a strong equity position allowing it to re-emerge as a stable, fully-funded publicly traded company on SIX Operating Liabilities CHF23m Operating Liabilities Liquidity Con
Slide 9: Evolva shareholders will own a Resilient Business with Substantial Asset Backing
Evolva shareholders will own a Resilient Business with Substantial Asset Backing Post-restructuring rebound: In CHFm Plot Size profitability stabilizes and 250 margin expansion resumes 12.0% Kat. Nr. 10877 40,751 sqm 200 179 183 187 192 196 10.0% 163 167 171 175 Kat. Nr. 4242 11,518 sqm 150 156 154
Slide 10: Timeline
Timeline 27 May 2025 Submission of the Offer 4 July 2025 End of Initial Acceptance Period June-August 2025 Potential Extension of Acceptance Period (max. 6 months total) and Preliminary Creditor Engagement August-December 2025 Creditor Negotiations and Finalization of Composition Agreement (Nachlass
Slide 11: Conclusions
Conclusions • Evolva’s offer is fully funded, executable, and provides clarity from day one • Preserves operations and ensures continued care access for the region • Delivers immediate financial relief to municipalities and creditors • Avoids a costly and uncertain liquidation • Creates long-term va
Slide 12: Contacts
Contacts For all enquiries: Doris Rudischhauser investors@evolvaholding.com 12